Chan, Brandon Y H <br/><br/>
MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.  [electronic resource] 

 -  Cardiovascular research  01 2021 
 - 188-200 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-3245 
<br/><br/><label>Standard No.: </label>10.1093/cvr/cvaa017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cardiotoxicity<br/>Cell Line<br/>Disease Models, Animal<br/>Doxorubicin<br/>Doxycycline--pharmacology<br/>Extracellular Matrix--drug effects<br/>Fibrosis<br/>Heart Diseases--chemically induced<br/>Human Embryonic Stem Cells--drug effects<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 2--metabolism<br/>Matrix Metalloproteinase Inhibitors--pharmacology<br/>Mice, Inbred C57BL<br/>Mitochondria, Heart--drug effects<br/>Myocytes, Cardiac--drug effects<br/>Phenyl Ethers--pharmacology<br/>Protein Kinases--metabolism<br/>Proteolysis<br/>Ventricular Function, Left--drug effects<br/>Ventricular Remodeling--drug effects<br/>Mice